ZA955676B - Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 - Google Patents

Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2

Info

Publication number
ZA955676B
ZA955676B ZA955676A ZA955676A ZA955676B ZA 955676 B ZA955676 B ZA 955676B ZA 955676 A ZA955676 A ZA 955676A ZA 955676 A ZA955676 A ZA 955676A ZA 955676 B ZA955676 B ZA 955676B
Authority
ZA
South Africa
Prior art keywords
tumor rejection
rejection antigen
hla
nucleic acid
acid sequence
Prior art date
Application number
ZA955676A
Inventor
Vincent Brichard
Aline Van Pel
Pierre Coulie
Thierry Boon-Falleur
Etienne De Plaen
Catia Traversari
Thomas Wolfel
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of ZA955676B publication Critical patent/ZA955676B/en

Links

ZA955676A 1994-07-08 1995-07-07 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 ZA955676B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27235194A 1994-07-08 1994-07-08

Publications (1)

Publication Number Publication Date
ZA955676B true ZA955676B (en) 1996-03-19

Family

ID=23039426

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955676A ZA955676B (en) 1994-07-08 1995-07-07 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2

Country Status (1)

Country Link
ZA (1) ZA955676B (en)

Similar Documents

Publication Publication Date Title
HUT37459A (en) Process for preparing improved nucleinic acid reagents
YU44797B (en) Process for producing substituted pyridinsulphonamde compound
PT84237A (en) Process for preparing neurite-promoting factor
HUT45258A (en) Process for producing new condenzed thieno-1,4-diazepines
EG18789A (en) Process for producing tetraalkyl ethenylidene-bisphosphonates
DE3665581D1 (en) 9-halogenprostaglandines, process for their manufacture
HUT43104A (en) Process for producing human antibodies
GB2197323B (en) Antibodies
EP0268999A3 (en) Process for producing t-butyl methacrylate
EP0772626A4 (en) Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2
YU62688A (en) Process for obtaining cyclical peptides
HUT37804A (en) Process for preparing peptides
ZA955676B (en) Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
GB2179348B (en) Process for the preparation of 6-d-(a)-(4-ethyl-2,3-dioxo-1-piperazinylcarbonylamino)-d-phenylacetamido-penicillanic acid
HUT46009A (en) Process for producing 7-bromo-beta-carboline compounds
GB8530915D0 (en) Synthesizing long chain dna
GB8311823D0 (en) Preparing chemical intermediates
GB8819633D0 (en) Process for producing trialkylarsenic compound
HUT45481A (en) Process for producing 5-amino-salicylic acid
HUT48264A (en) Process for producing azetidinon-n-/phosphono-methyl/-esters
HUT43107A (en) Process for producing vaccine against melanome
PL266755A1 (en) Method for manufacturing 6-amine-1,2-dihydro-1-hydroxy-2-amine-4-piperidinepyrimidine
EP0227810A4 (en) Processes for producing uromodulin.
YU159587A (en) Process for obtaining hynolin-2,3-dicarbonic acid
GB8708546D0 (en) Compound process